SpCas9 mRNA encodes the widely used CRISPR nuclease for efficient genome editing in mammalian cells. Delivery of mRNA enables rapid, transient Cas9 expression that reduces persistent nuclease exposure while supporting robust editing when paired with synthetic sgRNAs in research workflows.
- Enables efficient gene knockout and precise sequence modification
- Pairs with synthetic gRNAs for high on-target editing performance
- Supports transient nuclease expression for controlled editing activity
- Suitable for ex vivo cell engineering and in vivo genome editing research
hfCas12Max mRNA encodes a high-fidelity Cas12 nuclease engineered for precise genome editing with reduced off-target activity. Transient mRNA delivery enables controlled nuclease expression while supporting efficient editing when paired with compatible CRISPR guide RNAs.
- Improves editing precision with reduced off-target activity
- Expands genomic access through broad PAM compatibility
- Supports transient, controlled nuclease expression
- Designed for ex vivo cell engineering and in vivo editing applications
E. coli High-Yield Cell-Free Protein Expression Kit
Built for diverse needs and high‑performance workflows, this cell-free protein expression kit leverages the Continuous Exchange Cell-Free (CECF) principle along with an enhanced E.coli lysate to achieve medium-to-preparative-scale protein yields from plasmid DNA. It supports efficient and scalable production of up to 6-mg protein per run.
- High-yield CECF system enables optimized plasmid-based expression scalable from 0.5 mg to 6 mg per 1-mL reaction
- Ideal for structural biology workflows including NMR spectroscopy and X-ray crystallography thanks to a preparative-scale yield
- Flexible amino acid supply allows substitution of methionine for labeling studies
- Optimized for thermomixer-based operation, ensuring consistent CECF exchange and robust yields
E. coli Cell-Free Protein Expression Kit
Go from genes to proteins in hours. This fast cell‑free protein synthesis system uses optimized E. coli lysates and supports both circular and linear DNA templates to produces up to 20 µg of functional protein in ~4 hours. Ideal for rapid screening, parallel expression, and workflow scaling in tubes or microplates.
- High yield E. coli lysate drives efficient coupled transcription/translation, generating up to 20-µg protein per 50-µL reaction in ~4 h
- Supports linear and plasmid DNA for rapid construct screening without cloning, improving early expression workflows
- Flexible format works in microplates or tubes, enabling scalable, parallelized protein production
- Suitable for optimization studies, including chaperone or additive screening to enhance active protein yield
This validated controls kit is engineered for SpCas9 gene editing in human cells. It enables the precise assessment of cleavage efficiency and specificity by providing benchmark positive and negative gRNAs targeting a known locus. These controls are essential for optimizing transfection or electroporation protocols, validating sgRNA delivery, and quantifying on-target indel formation for reliable data normalization.
- Validate SpCas9 editing activity with positive and negative controls for human gene targets
- Establish a benchmark for quantifying on-target cleavage efficiency and indel formation
- Normalize experimental data to distinguish delivery failure from ineffective gRNA design
eSpOT-ON Recombinant Protein
eSpOT-ON nuclease is an engineered high-fidelity Cas9 protein designed for therapeutic applications. It offers high on-target editing efficiency while minimizing off-target activity, making it a safer choice for precise cell and gene therapy development. This Cas9 protein is optimized for both accuracy and safety, providing a reliable solution for your gene editing needs.
- Engineered for high on-target efficiency and reduced off-target effects.
- Minimizes off-target edits, enhancing safety in therapeutic applications.
- Produces staggered DNA cuts, which can improve DNA integration.
- Validated for safety and specificity in cell and gene therapies
eSpOT-ON is an engineered high-fidelity Cas9 variant, designed for therapeutic gene editing. Delivered in mRNA format, eSpOT-ON provides superior on-target activity with low off-target effects. This nuclease has been validated in preclinical studies and is ready to support your next breakthrough in cell and gene therapy development.
- Engineered for precise and safe genome editing.
- Significantly reduces off-target editing.
- Lowers the risk of chromosomal translocations.
- Validated in a wide range of human cell lines, including iPSCs.
T4 RNA Ligase II joins 3'-OH RNA to 5'-phosphorylated oligos within duplex contexts, reducing adapter dimers and artifacts. It produces cleaner small RNA libraries and supports dsRNA nick sealing and RNA circularization at various scales.
- Duplex-guided ligation minimizes adapter dimers
- Creates purer small RNA libraries and profiles
- Facilitates dsRNA nick sealing and circularization
- Suitable for both pilot and high-throughput workflows
Pyrophosphatase, Inorganic
In IVT, accumulating pyrophosphate (PPi) inhibits T7 and other RNA polymerases. Inorganic pyrophosphatase hydrolyzes PPi to phosphate, preventing product inhibition and sustaining transcription for higher, cleaner mRNA yields at standard reaction conditions. Maximize IVT yield by removing PPi product inhibition. Improve full‑length purity and reduce truncated RNA. Simple spike‑in; no buffer changes to your mix. Cost‑efficient: more mRNA per run saves template and NTPs.
- Maximize IVT yield by removing PPi product inhibition
- Improve full‑length purity and reduce truncated RNA
- Simple spike‑in; no buffer changes to your mix
- Cost‑efficient: more mRNA per run saves template and NTPs